F11, CPTAC-3420 - CPTAC Assay Portal (original) (raw)

Please include the following statement when referencing the CPTAC Assay Portal

We would like to acknowledge the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) Assay Portal (assays.cancer.gov) for developing assays and establishing criteria for the assays described in this publication.

Protein Sequence hover to view complete sequence

non-CPTAC-3420: View additional TSESGLPSTR data

10 20 30 40 50
MTSLHQVLYF IFFASVSSEC VTKVFKDISF QGGDLSTVFT PSATYCRLVC
60 70 80 90 100
THHPRCLLFT FMAESSSDDP TKWFACILKD SVTEILPMVN MTGAISGYSF
110 120 130 140 150
KQCPQQLSTC SKDVYVNLDM KGMNYNSSVV KNARECQERC TDDAHCQFFT
160 170 180 190 200
YATGYFPSVD HRKMCLLKYT RTGTPTTITK LNGVVSGFSL KSCGLSNLAC
210 220 230 240 250
IRDIFPNTVL ADLNIDSVVA PDAFVCRRIC THHPTCLFFT FFSQAWPKES
260 270 280 290 300
QRHLCLLKTS ESGLPSTRIT KSHALSGFSL QHCRHSVPVF CHPSFYNDTD
310 320 330 340 350
FLGEELDIVD VKGQETCQKT CTNNARCQFF TYYPSHRLCN ERNRRGRCYL
360 370 380 390 400
KLSSNGSPTR ILHGRGGISG YSLRLCKMDN VCTTKINPRV VGGAASVHGE
410 420 430 440 450
WPWQVTLHIS QGHLCGGSII GNQWILTAAH CFSGIETPKK LRVYGGIVNQ
460 470 480 490 500
SEINEGTAFF RVQEMIIHDQ YTTAESGYDI ALLKLESAMN YTDFQRPICL
510 520 530 540 550
PSKGDRNAVH TECWVTGWGY TALRGEVQST LQKAKVPLVS NEECQTRYRR
560 570 580 590 600
HKITNKMICA GYKEGGKDTC KGDSGGPLSC KYNGVWHLVG ITSWGEGCGQ
610 620 624
KERPGVYTNV AKYVDWILEK TQTV

Data source: UniProt


Position of Targeted Peptide Analytes Relative to SNPs, Isoforms, and PTMs

Uniprot Database Entry PhosphoSitePlus ®

Click a point on a node

to view detailed assay information below

All other points link out to UniProt


Phosphorylation Acetylation Ubiquitylation Other

loading

Loader


Assay Details for non-CPTAC-3420 Collapse assay details

Data source: Panorama

Official Gene Symbol

F11

Peptide Sequence

TSESGLPSTR

Modification Type

unmodified

Protein - Site of Modification

N/A

Peptide - Site of Modification

N/A

Peptide Start

259

Peptide End

268

CPTAC ID

non-CPTAC-3420

Peptide Molecular Mass

1,033.5040

Species

Mus musculus (Mouse)

Assay Type

Direct MRM

Matrix

Plasma

Submitting Laboratory

UVic-Genome BC Proteomics Centre

Submitting Lab PI

Christoph Borchers


Publication

View Details (opens in a new window)

Molecular phenotyping of laboratory mouse strains using 500 multiple reaction monitoring mass spectrometry plasma assays. Michaud SA, Sinclair NJ, Petrošová H, Palmer AL, Pistawka AJ, Zhang S, Hardie DB, Mohammed Y Eshghi A1, Richard VR, Sickmann A, Borchers CH. Commun Biol. 2018 Jun 27;1:78. doi: 10.1038/s42003-018-0087-6. eCollection 2018.


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument

Agilent 6490/6495 QQQ

Internal Standard

synthetic peptide

Peptide Standard Purity

>95%

Peptide Standard Label Type

13C and 15N at C-terminus R

LC

1290 LC (Agilent)

Column Packing

Zorbax Eclipse Plus C18, 1.8 µm

Column Dimensions

2.1 x 150 mm

Flow Rate

400 µL/min


Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader


Repeatability

Data source: Panorama

| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CVequation | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | y8 (1+) | 7.8 | 9.7 | 4.9 | 17.4 | 10.9 | 5.3 | 19.1 | 14.6 | 7.2 | 15 | 15 | 15 | | y7 (1+) | 11.7 | 6.6 | 9.1 | 51.9 | 19.3 | 11 | 53.2 | 20.4 | 14.3 | 15 | 15 | 15 | | y6 (1+) | 5 | 5.4 | 8 | 16 | 7.2 | 10.1 | 16.8 | 9 | 12.9 | 15 | 15 | 15 | | y4 (1+) | 7.4 | 8.5 | 5.7 | 15.2 | 10.7 | 4.7 | 16.9 | 13.7 | 7.4 | 15 | 15 | 15 | | y8 (2+) | 10.1 | 5.8 | 7.2 | 18.2 | 11.4 | 7.2 | 20.8 | 12.8 | 10.2 | 15 | 15 | 15 | | sum | 6.5 | 4.2 | 3.5 | 28.9 | 8.2 | 3.5 | 29.6 | 9.2 | 4.9 | 15 | 15 | 15 |



Additional Resources and Comments